Skip to search formSkip to main contentSkip to account menu

raltegravir potassium

Known as: N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[ (5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Monopotassium Salt, Potassium, Raltegravir, Raltegravir Potassium [Chemical/Ingredient] 
The orally bioavailable potassium salt of a human immunodeficiency virus (HIV) integrase strand transfer inhibitor (HIV-1 INSTI) with HIV-1 antiviral… 
National Institutes of Health

Related topics

Related topics

14 relations

Broader (3)

Anti-HIV AgentsHIV Integrase Inhibitorsraltegravir
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Narrower (2)

IsentressMK 0518

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Synthesis of Raltegravir
Significance: Raltegravir potassium (Isentress®) is an HIV integrase inhibitor manufactured by Merck & Co. (G. R. Humphrey et al… 
2014
2014
DEVELOPMENT AND VALIDATION OF RP- HPLC METHOD FOR DETERMINATION OF RALTEGRAVIR AND ITS IMPURITIES IN BULK DRUG AND DOSAGE FORMS
A simple, sensitive, rapid high performance liquid chromatography methodhas been developed for estimation of related compounds… 
2010
2010
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2010
2010
New Antimicrobial Agents Approved by the U.S. Food and Drug Administration from 2007 to 2009 and New Indications for Previously Approved Agents
12 Apr 2007 Altabax (topical ointment) Retapamulin Glaxo Group For topical treatment of impetigo due to Staphylococcus aureus… 
2010
2010
Gateways to clinical trials.
[¹¹C]RAC; (18)F-Fluoromisonidazole; 89-12; 9-[¹⁸F]Fluoropropyl-(+)-dihydrotetrabenazine; Adalimumab, Adecatumumab, ADMVA, ADXS-11… 
2010
2010
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2009
2009
Process for preparing amorphous raltegravir potassium
Process for preparing raltegravir potassium in amorphous form comprising: a. raltegravir potassium stirring in water; b. removing… 
2009
2009
Gateways to clinical trials.
(+)-Dapoxetine hydrochloride, [(123)I]-BZA, 9-Aminocamptothecin; Abacavir sulfate/lamivudine, Adalimumab, Adefovir dipivoxil… 
2009
2009
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2008
2008
A polar radical pair pathway to assemble the pyrimidinone core of the HIV integrase inhibitor raltegravir potassium.
The UN and WHO currently estimate that 40 million people are living with HIV/AIDS worldwide. Combination therapies using reverse… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)